Darzalex 400 mg Injection Darzalex 400 mg Injection Darzalex 400 mg Injection Darzalex 400 mg Injection Darzalex 400 mg Injection Darzalex 400 mg Injection Darzalex 400 mg Injection

Darzalex 400 mg Injection

57590.0 INR/VIAL

Product Details:

  • Origin of Medicine United States of America
  • Physical Form Liquid
  • Recommended For DOCTOR
  • Quantity 5 Pieces
  • Click to view more
X

Darzalex 400 mg Injection Price And Quantity

  • 5 Piece
  • 57590.0 INR/VIAL

Darzalex 400 mg Injection Product Specifications

  • United States of America
  • Liquid
  • DOCTOR
  • 5 Pieces

Darzalex 400 mg Injection Trade Information

  • 1 Week

Product Description

Darzalex 400 mg Injection is an innovative therapeutic option designed to combat specific cancers, particularly multiple myeloma, a malignancy impacting plasma cells, essential components of the immune system. This medication can be utilized on its own or in conjunction with other cancer treatments to enhance effectiveness. By targeting and inhibiting the activity of certain proteins found on the surface of myeloma cells, Darzalex works to slow down tumor growth and promote cell death. While it offers significant benefits in managing this challenging condition, patients should be aware that Darzalex may lead to reductions in platelet and white blood cell counts, which are crucial for blood clotting and fighting infections, respectively. Common side effects may include reactions at the injection site, as well as systemic symptoms such as fever, chills, rash, headache, nausea, dizziness, and in some cases, difficulty breathing. As with any treatment, it's important to discuss potential risks and benefits with a healthcare professional to ensure optimal care. With its targeted approach, Darzalex represents a promising advancement in the treatment landscape for multiple myeloma patients.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top